欧康维视生物-B（01477）于2026年3月5日发布截至2026年2月28日的月度股份变动报告。公告显示，公司注册股本仍为5,000,000,000股，面值每股USD 0.00001，注册股本总额USD 50,000，与上月持平。
公司已发行股份（不含库存股份）期末结存为815,382,414股，库存股份为20,949,500股，合计836,331,914股。当月无新增发行或回购并注销股份，股本结构保持不变。
在股份期权及股权激励方面，2018年采纳的员工购股权计划结存期权数量为13,317,816份，无新增行使或取消。2021年购股权计划月内失效3,520份期权，结存期末为37,591,614份期权，尚未行使的期权未发生新股发行。2021年股份奖励计划亦于月内失效3,220股奖励，未导致股份发行。
公司表示，截至本月末整体已发行股本及公眾持股量符合香港联交所相关规定。公告由董事Lian Yong CHEN签署，并确认所有股份变动均已获得正式授权及遵守适用法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.